This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,540.54 firm fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of November 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the Department of Defense and military medical institutions.
Generated 2/25/25, 10:13 AM